Coherus BioSciences, Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. CHRS has around 5.5M shares in the U.S. ETF market. The largest ETF holder of CHRS is the SPDR S&P Biotech ETF (XBI), with approximately 1.51M shares. Investors may also find of interest that the ETF with the largest allocation to CHRS stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 1.02%. On average, U.S. ETFs allocate 0.12% of CHRS to their portfolios.
Additionally, CHRS is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CHRS as a holding is the Invesco DWA NASDAQ Momentum ETF (DWAQ), with a return of 17.61%.